Vijay G. Sankaran
@bloodgenes.bsky.social
📤 3371
📥 1263
📝 267
Pediatric Hematologist/Oncologist, Geneticist, Stem Cell Biologist bloodgenes.org
reposted by
Vijay G. Sankaran
Richard Sever
6 days ago
Saddened to learn of the death of Greg Hannon, a former CSHL colleague and giant of modern molecular biology
www.cruk.cam.ac.uk/news/in-memo...
loading . . .
In Memoriam: Professor Greg Hannon (1964–2026) - Cancer Research UK Cambridge Institute
Greg was already a world-renowned scientist when appointed Director, and for the community, he was a visionary leader, a cherished mentor, and a singular force of nature whose influence shaped the research landscape.
https://www.cruk.cam.ac.uk/news/in-memoriam-professor-greg-hannon/
1
37
7
reposted by
Vijay G. Sankaran
Ran Blekhman
10 days ago
I wrote about why every lab should have AI use guidelines, and how to do it.
open.substack.com/pub/blekhman...
loading . . .
You need to make AI guidelines for your lab
Here's why you should, and how to start
https://open.substack.com/pub/blekhman/p/you-need-to-make-ai-guidelines-for?utm_campaign=post-expanded-share&utm_medium=web
3
180
64
reposted by
Vijay G. Sankaran
Juan C. Landoni
13 days ago
Our paper is now out in Science! Super excited to share our discovery that
#mitochondria
#pearling
is the elusive mechanism driving the regular distribution and inheritance of
#mtDNA
nucleoids 🧬 [1/6]
3
170
68
www.fondazionetelethon.it/en/stories-a...
loading . . .
In memory of Claudio Bordignon, pioneer of gene therapy - Telethon
His work combined scientific vision, experimental rigor and a constant focus on the potential impact of research for patients affected by severe inherited diseases.
https://www.fondazionetelethon.it/en/stories-and-news/news/from-telethon-foundation/in-memory-of-claudio-bordignon-pioneer-of-gene-therapy/
15 days ago
0
5
1
❓A one-time, durable, and even reversible way to prevent thrombosis? In this preprint, led by
@lrbzldz.bsky.social
, we show that epigenome editing of 🩸
#StemCells
can durably reprogram platelet function:
www.biorxiv.org/content/10.6...
17 days ago
1
15
6
Amazing group!!! Congratulations!!! 👏👏👏
add a skeleton here at some point
22 days ago
0
1
1
Amazing documentary on cystic fibrosis 🫁 and Michael Welsh’s extraordinary contributions to therapies that have transformed so many lives:
www.youtube.com/watch?v=PIXC...
loading . . .
Giving Back Breath: How an Iowa doctor led a breakthrough cystic fibrosis treatment
YouTube video by DMRegister
https://www.youtube.com/watch?v=PIXCsqXfOR0
23 days ago
0
4
0
reposted by
Vijay G. Sankaran
Eric Topol
23 days ago
Our thymus gland, neglected and assumed to be non-functional in adults, is taking center stage for healthy aging. Two new landmark studies
erictopol.substack.com/p/your-thymu...
loading . . .
Your Thymus and Your Healthspan
New landmark studies using AI to determine thymus health and its link to major outcomes
https://erictopol.substack.com/p/your-thymus-and-your-healthspan
1
119
23
🚨🧬🩸 Delighted to have this
@naturerevgenet.bsky.social
review w/ Michael Poeschla published today - Genetic Influences on
#hematopoiesis
:
rdcu.be/e9vlD
loading . . .
Genetic influences on haematopoiesis
Nature Reviews Genetics - Haematopoiesis is a classic process for understanding the genetic basis of human health and disease. In this Review, Poeschla and Sankaran discuss this history and more...
https://rdcu.be/e9vlD
24 days ago
1
13
3
Incredibly fortunate to work with this amazing team and to learn from them every day!!
@hhmi-science.bsky.social
@bostonchildrens.bsky.social
@danafarber.bsky.social
@broadinstitute.org
28 days ago
0
18
1
reposted by
Vijay G. Sankaran
Eric Topol
about 1 month ago
erictopol.substack.com/p/the-missin...
A biomarker you might want to know about
loading . . .
The Missing CHIP
Ignoring a very informative lab test
https://erictopol.substack.com/p/the-missing-chip
1
103
31
Great to see a complementary screen from the
@fda.gov
identify
#ferroptosis
inhibition as critical for expanding human 🩸
#stemcells
in
@moltherapy.bsky.social
:
www.cell.com/molecular-th...
Nicely supports our prior findings:
www.nature.com/articles/s41...
about 1 month ago
0
3
1
reposted by
Vijay G. Sankaran
James Olzmann
about 1 month ago
1/3 Thrilled to see our paper led by Kirandeep Deol is out in Nature Structural & Molecular Biology! CRISPR screens to uncover a role for vitamin B2 metabolism in stabilizing FSP1 via FAD, revealing a new way vitamins regulate ferroptosis.
www.nature.com/articles/s41...
loading . . .
Vitamin B2 metabolism promotes FSP1 stability to prevent ferroptosis - Nature Structural & Molecular Biology
Here, Deol et al. use genetic screens in gene-edited reporter cell lines to identify regulators of ferroptosis suppressor protein 1 (FSP1) expression and stability. They show that vitamin B2 metabolis...
https://www.nature.com/articles/s41594-026-01759-x
2
58
16
reposted by
Vijay G. Sankaran
Pedro Friedmann Angeli
about 1 month ago
Happy to share the final version of the study where we describe a central role for vitaminB2 in regulating membrane redox state - some new cool experiments were added since the preprint was posted - pls check this out thttps://www.nature.com/articles/s41556-025-01856-x
loading . . .
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance - Nature Cell Biology
After performing a focused CRISPR–Cas9 screen, Skafar et al. identify riboflavin (vitamin B2) as a regulator of FSP1 stability that modulates phospholipid peroxidation and ferroptosis sensitivity in c...
https://www.nature.com/articles/s41556-025-01856-x
2
37
14
🙏 🙏
@samhegde.bsky.social
!! Fantastic talk at
#KSHemato26
from
@gaoteng.bsky.social
on our recent advances in mitochondrial 🧬 lineage tracing! Please check out the preprint:
www.biorxiv.org/content/10.6...
add a skeleton here at some point
about 2 months ago
0
7
0
reposted by
Vijay G. Sankaran
Keystone Symposia
about 2 months ago
Join us in congratulating the award winners from the National Heart, Lung, and Blood Institute,
@niaidnews.bsky.social
, and the Keystone Symposia Future of Science Fund at
#KSHemato26
in Keystone! 👏
#FutureofScience
#hematopoiesis
#bonemarrow
@bloodgenes.bsky.social
@beaudinlab.bsky.social
0
2
2
Check out this fascinating MPRA in human hematopoietic cells from Satish Nandakumar,
@tewhey.bsky.social
, and team!!
www.biorxiv.org/content/10.6...
about 2 months ago
0
14
6
reposted by
Vijay G. Sankaran
New Scientist
about 2 months ago
Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory infection RSV than existing antibody therapies, and are now being developed as preventative treatments
loading . . .
Paediatricians’ blood used to make new treatments for RSV and colds
Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory infection RSV than existing antibody therapies, and are now being developed as preventative treatments
https://www.newscientist.com/article/2516079-paediatricians-blood-used-to-make-new-treatments-for-rsv-and-colds/?utm_term=Autofeed&utm_medium=SOC&utm_source=Bluesky#Echobox=1771556582
13
422
188
reposted by
Vijay G. Sankaran
Eric Topol
about 2 months ago
The $100 whole human genome sequence finally reached!
www.sandiegouniontribune.com/2026/02/19/s...
12
257
88
Fascinating article by the insightful
@jasonmast.bsky.social
!! Maybe 🩸 stem cell expansion could help?:
www.nature.com/articles/s41...
add a skeleton here at some point
about 2 months ago
0
5
1
Exciting clinical study in
@nejm.org
from Cherqui Lab
@ucsdhealth.bsky.social
showing how 🩸 stem cell 🧬 therapy can treat cystinosis, a lysosomal metabolic disorder! Expanding the scope of 🩸🧬 tx!
www.nejm.org/doi/full/10....
about 2 months ago
0
5
2
Fascinating paper in
@nature.com
today about how 🧬 variant impacting cyclin D3 alters malaria infectivity of red cells!
www.nature.com/articles/s41...
,
www.nature.com/articles/d41...
... Follows up on some of our original studies from over 14 years ago:
genesdev.cshlp.org/content/26/1...
about 2 months ago
0
7
0
Check out this important advance in mitochondrial 🧬 lineage tracing by
@gaoteng.bsky.social
and
@wengchen.bsky.social
from our group, in collaboration with
@jswlab.bsky.social
👇👇
add a skeleton here at some point
about 2 months ago
0
16
3
reposted by
Vijay G. Sankaran
Waggoner Lab
2 months ago
@biorxivpreprint.bsky.social
Modeling mitochondrial inheritance enables high-precision single-cell lineage tracing in humans
www.biorxiv.org/content/10.6...
@bloodgenes.bsky.social
@jswlab.bsky.social
@bostonchildrens.bsky.social
@hhmi-science.bsky.social
@broadinstitute.org
0
17
5
🙏 🙏
add a skeleton here at some point
2 months ago
0
4
1
Really grateful to all the wonderful folks at
@yalecancer.bsky.social
for hosting me, particularly
@halenelab.bsky.social
!! 🙏 🙏
add a skeleton here at some point
2 months ago
0
3
0
reposted by
Vijay G. Sankaran
Nature Reviews Cancer
2 months ago
loading . . .
Inherited resilience
Nature Reviews Cancer, Published online: 10 February 2026; doi:10.1038/s41568-026-00914-2Mutant haematopoietic stem cells display broad fitness variation, suggesting that protective mechanisms may limit clonal expansion and malignant transformation. Now, Agarwal et al. identify a germline noncoding variant that confers resilience to clonal haematopoiesis of indeterminate potential (CHIP) by dampening expression of the RNA-binding protein MSI2.
http://dlvr.it/TQtcWB
0
4
3
reposted by
Vijay G. Sankaran
Eric Topol
3 months ago
Another major triumph for a refractory autoimmune disease—hemolytic anemia—through engineered T cells
@nejm.org
nejm.org/doi/full/10....
loading . . .
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia | NEJM
In patients with autoimmune hemolytic anemia (AIHA), the risk of relapse is high owing to persistent autoreactive B-cell activity. Multirefractory AIHA is a more advanced stage of disease that is d...
https://nejm.org/doi/full/10.1056/NEJMoa2509820
3
124
24
Thank you to
@aacrjournals.bsky.social
and Elie Dolgin for this wonderful piece covering our work! Features great insights from Danielle Hammond & Lachelle Weeks:
aacrjournals.org/cdnews/news/...
loading . . .
A Genetic Brake on Blood Cancer Risk
A large genetic analysis uncovered a variant that restrains clonal hematopoiesis by slowing the growth of mutated blood stem cells linked to myeloid malignancies. The mechanisms involved may offer tar...
https://aacrjournals.org/cdnews/news/2973/A-Genetic-Brake-on-Blood-Cancer-Risk
3 months ago
0
6
0
Enjoyed writing this Preview with Jonas Gudera on GoT-Multi 🪄 A powerful
#singlecell
approach from the teams of Anna Nam and
@lgmartelotto.bsky.social
Preview:
www.cell.com/cell-genomic...
Paper:
www.cell.com/cell-genomic...
3 months ago
0
5
1
reposted by
Vijay G. Sankaran
Emma Dann
3 months ago
Together with
@ronghuizhu.bsky.social
, we are thrilled to present our new perturb-seq study of 22M primary CD4+ T cells, across donors and timepoints – the result of a decade-long collaboration between the Marson
@marsonlab.bsky.social
and Pritchard
@jkpritch.bsky.social
labs 🧵
tinyurl.com/gwt2025
loading . . .
Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits
Gene regulatory networks encode the fundamental logic of cellular functions, but systematic network mapping remains challenging, especially in cell states relevant to human biology and disease. Here, ...
https://tinyurl.com/gwt2025
2
64
33
Interested in
#hematopoiesis
🩸? Please join us at the
@keystonesymposia.bsky.social
Hematopoiesis meeting with an amazing lineup (only some of whom are shown) this February! Poster Abstracts due by February 3rd.
#KSHemato26
keysym.us/KSHemato26
3 months ago
1
8
1
reposted by
Vijay G. Sankaran
Waggoner Lab
4 months ago
Dysregulated activation responses is a defining feature of HSPC aging and establish proliferative stress–based xenotransplantation is a powerful platform for investigating age-related hematopoietic dysfunctions
@jem.org
@dimiccolab.bsky.social
rupress.org/jem/article-...
1
6
4
Delighted to have our work on 🧬 resilience to 🩸cancer led by
@g-agarwal.bsky.social
& amazing collaborators, including
@kharaslab.bsky.social
, published in
@science.org
:
www.science.org/doi/10.1126/...
🧵
3 months ago
3
56
16
reposted by
Vijay G. Sankaran
Eric Topol
3 months ago
New
@science.org
today Discovery of a genomic variant that protects against blood cancer by reducing risk of CHIP (blood stem cell mutation clones, common with aging)
@bloodgenes.bsky.social
@kharaslab.bsky.social
science.org/doi/10.1126/...
loading . . .
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation
Somatic mutations that increase the fitness of hematopoietic stem cells (HSCs) drive their expansion in clonal hematopoiesis (CH) and predispose individuals to blood cancers. Population variation in t...
http://science.org/doi/10.1126/science.adx4174
2
211
60
Rest in peace. We need to develop better treatments for so many individuals impacted by 🩸 and other cancers!
add a skeleton here at some point
4 months ago
0
5
2
Enjoyed writing this commentary with
@g-agarwal.bsky.social
for
@bloodjournal.bsky.social
:
ashpublications.org/blood/articl...
Covers an exciting paper from Tapper and co:
ashpublications.org/blood/articl...
#mpnsm
4 months ago
0
11
2
reposted by
Vijay G. Sankaran
Molly Przeworski
4 months ago
Happy to highlight an essay I wrote together with
@marcdemanuel.bsky.social
,
@natanaels.bsky.social
and Anastasia Stolyarova, trying to think through what sets the mutation rate of a cell type in an animal species:
www.biorxiv.org/content/10.6...
1/n
loading . . .
What sets the mutation rate of a cell type in an animal species?
Germline mutation rates per generation are strikingly similar across animals, despite vast differences in life histories. Analogously, in at least one somatic cell type, mutation rates at the end of l...
https://www.biorxiv.org/content/10.64898/2025.12.19.695482v1
2
124
64
reposted by
Vijay G. Sankaran
Roman Doll
4 months ago
Excited to share that a part of my PhD work is online now on BioRxiv!
www.biorxiv.org/content/10.6...
We developed a genome editing approach to target the JAK2 V617F mutation and demonstrate its potential to alleviate MPN hallmarks in primary patient cells. Thread 👇
loading . . .
4
22
8
Really enjoying "Mia the Marvelous Lab Explorer: The Case of Leo’s Missing Energy" by
@kmirza.bsky.social
and Lotte Mulder, while mom is out treating children like Leo with leukemia!
4 months ago
0
2
0
reposted by
Vijay G. Sankaran
Eric Topol
4 months ago
What does it take to achieve the highest level of human performance? Across athletics, science, chess, and music
@science.org
science.org/doi/10.1126/...
loading . . .
Recent discoveries on the acquisition of the highest levels of human performance
Scientists have long debated the origins of exceptional human achievements. This literature review summarizes recent evidence from multiple domains on the acquisition of world-class performance. We re...
https://science.org/doi/10.1126/science.adt7790
8
130
38
Terrific to have our paper, led by
@tjflemin.bsky.social
, featured as a plenary article in
@bloodjournal.bsky.social
today:
ashpublications.org/blood/articl...
4 months ago
1
20
5
reposted by
Vijay G. Sankaran
Jonathan Pritchard
4 months ago
Our latest preprint revisits the classic model of mutation-selection balance. Do human recessive genes fit Haldane's 100-year old model? This work is by the wonderful
@jonj-udd.bsky.social
, and co-mentored by
@jeffspence.github.io
www.biorxiv.org/content/10.6...
loading . . .
Allele Frequencies at Recessive Disease Genes are Mainly Determined by Pleiotropic Effects in Heterozygotes
The classic theory of mutation-selection balance predicts the equilibrium frequency of genetic variation under negative selection. The model predicts a simple relationship between the total frequency ...
https://www.biorxiv.org/content/10.64898/2025.12.05.692665v1
4
113
57
reposted by
Vijay G. Sankaran
Eric Topol
4 months ago
A major advance in cancer using multimodal AI to do virtual proteomics of H&E slides, unraveling the tumor microenvironment, key proteins, biomarkers, and informing prognosis
@cellcellpress.bsky.social
@hoifungpoon.bsky.social
@msftresearch.bsky.social
cell.com/cell/fulltex...
loading . . .
Multimodal AI generates virtual population for tumor microenvironment modeling
GigaTIME leverages multimodal AI to generate virtual multiplex immunofluorescence (mIF) profiles from standard H&E slides, enabling comprehensive tumor immune microenvironment modeling across a large ...
https://cell.com/cell/fulltext/S0092-8674(25)01312-1
2
78
22
reposted by
Vijay G. Sankaran
Eric Topol
4 months ago
A big advance, folks, for off-the-shelf, universal, engineered (base-edited) T cells achieving complete response vs incurable leukemia in several patients
www.nejm.org/doi/full/10....
3
320
87
Inspiring presentations by Radek Skoda & Ruben Mesa for the Beutler prizes and lectures!!! So incredibly well deserved!
#ASH25
4 months ago
0
5
0
Amazing talk from Nancy Speck, who is the 2025 recipient of the E. Donnall Thomas Lecture and Award from
@ash.hematology.org
!!! Congratulations, Nancy!
#ASH25
4 months ago
0
6
0
reposted by
Vijay G. Sankaran
Blood Journals Portfolio
4 months ago
Congratulations to Dr. Jorge Di Paola for winning the 2025 ASH Mentor Award and Dr. Diane Krause for winning the ASH Advancing Inclusive Excellence Award!
@ash.hematology.org
President Dr. Avalos was honored to present these at
#ASH25
0
17
2
Wow!! 🔥🔥 CDK4/6 inhibition prevents selection of
#ClonalHematopoiesis
with DNA-damage repair mutations after chemotherapy! Awesome presentation from Irenaeus Chan from
@kellybolton.bsky.social
lab!
#ASH25
4 months ago
0
20
3
Really enjoyed the fantastic session we had yesterday on applications of AI in hematology at
#ASH25
with
@wondermixtape.bsky.social
, Sanam Loghavi, and
@kdpsingh.bsky.social
!
4 months ago
0
13
2
Load more
feeds!
log in